Su Qian

Title: The Innovative Contributions of Inventor Su Qian

Introduction: Su Qian, an inventor based in Sayreville, NJ, has made significant strides in the field of biomedical research. With a focus on Alzheimer's disease, his work has implications for understanding and potentially treating this devastating condition.

Latest Patents: Su Qian holds a patent for a "Transgenic mouse expressing non-native wild-type and familial Alzheimer's Disease mutant presenilin 1 protein on native presenilin 1 null background." This invention relates to a transgenic non-human animal embryo lacking native presenilin 1 and a transgenic non-human animal possessing only a non-native presenilin 1. These transgenic animals and the cells derived from them are instrumental in studying the expression pattern, activity, and modulators of presenilin 1, as well as its role in Alzheimer's disease and other central nervous system disorders.

Career Highlights: Throughout his career, Su Qian has demonstrated a strong commitment to advancing research in neurology and genetics. His invention showcases his ability to bridge the gap between theoretical research and practical application, contributing valuable insights into the mechanisms of Alzheimer's disease.

Collaborations: Su Qian has collaborated with respected colleagues in his field, including Hui Zheng and Ping Jiang. These partnerships have fostered an environment of shared knowledge and innovation, ultimately enhancing the quality and scope of their research endeavors.

Conclusion: Su Qian stands out as a notable inventor whose contributions are paving the way for future advancements in the understanding of Alzheimer's disease. His innovative approach to biomedical research exemplifies the potential that transgenic models hold for studying complex neurological disorders.